These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clindamycin in the treatment of cerebral toxoplasmosis in a patient with AIDS]. Santos Gil I; Noguerado Asensio A; del Arco Galán C; García Polo I Rev Clin Esp; 1989 Jun; 185(1):47. PubMed ID: 2772341 [No Abstract] [Full Text] [Related]
4. Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient. Westblom TU; Belshe RB Scand J Infect Dis; 1988; 20(5):561-3. PubMed ID: 3222671 [TBL] [Abstract][Full Text] [Related]
5. An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis. Leport C; Bastuji-Garin S; Perronne C; Salmon D; Marche C; Briçaire F; Vilde JL J Infect Dis; 1989 Sep; 160(3):557-8. PubMed ID: 2760509 [No Abstract] [Full Text] [Related]
6. Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system. Ruf B; Pohle HD Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):183-6. PubMed ID: 2060525 [TBL] [Abstract][Full Text] [Related]
9. Low-dose alternate-day pyrimethamine for maintenance therapy in cerebral toxoplasmosis complicating AIDS. Bhatti N; Larson E J Infect; 1990 Jul; 21(1):119-20. PubMed ID: 2384677 [No Abstract] [Full Text] [Related]
10. [Cerebral toxoplasmosis in the acquired immunodeficiency syndrome. Study of the clinical, radiological, and pathological findings in 10 cases]. Bonaventura I; Romero F; Ortega A; Navarro C; Juste C; Codina Puiggrós A Med Clin (Barc); 1988 May; 91(1):1-6. PubMed ID: 3172889 [No Abstract] [Full Text] [Related]
11. [Induction of tolerance to sulfadiazine in a patient with acquired immunodeficiency syndrome]. Gilquin J; Magar Y; Acar JF; Blamoutier J Presse Med; 1988 Dec; 17(43):2306. PubMed ID: 2974963 [No Abstract] [Full Text] [Related]
12. [Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases]. González-Clemente JM; Miró JM; Pedrol E; Alvarez R; Gatell JM; Mallolas J; Graus F; Mercader JM; Guelar A; Jiménez de Anta MT Med Clin (Barc); 1990 Oct; 95(12):441-6. PubMed ID: 2084411 [TBL] [Abstract][Full Text] [Related]
13. [Cerebral toxoplasmosis as a cause of treatable dementia in an aged patient]. de la Fuente Fernández ; Díaz Benito JA; Rodríguez García JC; Piñeiro Gómez-Durán L Med Clin (Barc); 1991 Apr; 96(15):597-8. PubMed ID: 2051822 [No Abstract] [Full Text] [Related]
14. [Cerebral toxoplasmosis in patients with acquired immunodeficiency syndrome: does the early administration of treatment contribute to improve survival?]. Miralles R; Gallén M; Garcés JM; López-Colomés JL Med Clin (Barc); 1991 Feb; 96(7):276-7. PubMed ID: 2038224 [No Abstract] [Full Text] [Related]
15. Sulphadiazine desensitisation in AIDS patients. Bell ET; Tapper ML; Pollock AA Lancet; 1985 Jan; 1(8421):163. PubMed ID: 2857234 [No Abstract] [Full Text] [Related]
16. Role of clindamycin in the treatment of central nervous system toxoplasmosis. Rolston KV; Hoy J Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590 [TBL] [Abstract][Full Text] [Related]
17. Cerebral toxoplasmosis in patients with AIDS. Rossitch E; Carrazana EJ; Samuels MA Am Fam Physician; 1990 Mar; 41(3):867-73. PubMed ID: 2407076 [TBL] [Abstract][Full Text] [Related]
18. Role of clindamycin in the treatment of toxoplasmosis and pneumocystosis in patients with AIDS. Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):175-213. PubMed ID: 2060521 [No Abstract] [Full Text] [Related]
19. [Zidovudine efficacy and tolerance in 32 patients with cerebral toxoplasmosis in the acquired immunodeficiency syndrome]. Leport C; Chakroun M; Matheron S; Rozenbaum W; Dournon E; Regnier B Presse Med; 1988 Oct; 17(35):1813-4. PubMed ID: 2978327 [No Abstract] [Full Text] [Related]